These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The subjective experiences of people who regularly receive depot neuroleptic medication in the community. Phillips L, McCann E. J Psychiatr Ment Health Nurs; 2007 Sep; 14(6):578-86. PubMed ID: 17718731 [Abstract] [Full Text] [Related]
4. The effect of age on the pharmacological management of ambulatory patients treated with depot neuroleptic medications for schizophrenia and related psychotic disorders. Mamo DC, Sweet RA, Chengappa KN, Reddy RR, Jeste DV. Int J Geriatr Psychiatry; 2002 Nov; 17(11):1012-7. PubMed ID: 12404650 [Abstract] [Full Text] [Related]
5. The prescription of discretionary antipsychotic medication by state mental hospital psychiatrists. Benson PR. J Health Soc Behav; 1986 Mar; 27(1):28-43. PubMed ID: 2872249 [No Abstract] [Full Text] [Related]
6. [Depot Neuroleptic preparations in psychiatric practice (author's transl)]. Svestka J, Bártová D, Cesková E, Rysánek R. Cesk Psychiatr; 1981 Jun; 77(3):187-97. PubMed ID: 6119161 [No Abstract] [Full Text] [Related]
7. The risk/benefit ratio of depot neuroleptics: a Scandinavian perspective. Dencker SJ. J Clin Psychiatry; 1984 May; 45(5 Pt 2):22-7. PubMed ID: 6143744 [Abstract] [Full Text] [Related]
9. [Comparative study of delayed-action neuroleptics in psychiatric therapeutics]. Pellet J, Guyotat J, Marie-Cardine M, Dubor P, Favre-Tissot M, Caron F, Cottraux J. J Med Lyon; 1972 Apr 20; 53(227):591-8. PubMed ID: 4404295 [No Abstract] [Full Text] [Related]
10. Patterns and frequency of atypical antipsychotic prescribing in psychiatric medical centers: a cross-sectional national survey. Diatta T, Blazejewski S, Portier A, Lignot S, Quesnot A, Moore N, Fourrier-Réglat A. Fundam Clin Pharmacol; 2007 Aug 20; 21(4):371-8. PubMed ID: 17635175 [Abstract] [Full Text] [Related]
11. Risperidone depot in the treatment of psychosis associated with multiple sclerosis -- a case report. Hussain A, Belderbos S. J Psychopharmacol; 2008 Nov 20; 22(8):925-6. PubMed ID: 18308807 [Abstract] [Full Text] [Related]
12. Depot and oral antipsychotics: patient preferences and attitudes are not the same thing. Patel MX, De Zoysa N, Bernadt M, David A. J Psychopharmacol; 2009 Sep 20; 23(7):789-96. PubMed ID: 18583438 [Abstract] [Full Text] [Related]
13. [Depot neuroleptic agents]. Dröes JT. Ned Tijdschr Geneeskd; 1986 Dec 13; 130(50):2251-5. PubMed ID: 2880304 [No Abstract] [Full Text] [Related]
15. Clinical experience with pipothiazine palmitate (19552 R.P.) in hospitalized and open ward patients with functional psychoses. Salvesen C, Vaksdal K. Behav Neuropsychiatry; 2006 May 13; 5(7-12):3-7. PubMed ID: 4154740 [No Abstract] [Full Text] [Related]
16. [Psychiatry not mature for compulsory outpatient care]. Cullberg J, Forsén JO. Lakartidningen; 2006 May 13; 103(39):2885-6. PubMed ID: 17128924 [No Abstract] [Full Text] [Related]
17. The CPN and depot injections. Crossfield T. Nursing (Lond); 2006 May 13; 4(13):24-5. PubMed ID: 1974042 [No Abstract] [Full Text] [Related]
18. The attitude of patients towards antipsychotic depot treatment. Heres S, Schmitz FS, Leucht S, Pajonk FG. Int Clin Psychopharmacol; 2007 Sep 13; 22(5):275-82. PubMed ID: 17690596 [Abstract] [Full Text] [Related]
19. Patients in the early phases of schizophrenia and schizoaffective disorders effectively treated with risperidone long-acting injectable. Parellada E, Andrezina R, Milanova V, Glue P, Masiak M, Turner MS, Medori R, Gaebel W. J Psychopharmacol; 2005 Sep 13; 19(5 Suppl):5-14. PubMed ID: 16144781 [Abstract] [Full Text] [Related]
20. [Experiences with depot-neuroleptics in an after-care unit. Organization of the therapy exemplified with pipotiazine palmitate]. Salvesen C, Vaksdal K. Tidsskr Nor Laegeforen; 1973 Aug 30; 93(24):1699-703. PubMed ID: 4149082 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]